Denali Therapeutics Inc. (DNLI) Insider Trading

Name: Denali Therapeutics Inc. (DNLI) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 9, 2026): Chin Peter Scott (Chief Medical Officer): Sale of 1,654 shares, $36.9K.

Get alerted when insiders trade DNLI

Email address

Loading company data...

Beta

Loading company details...

Beta